- Home
- IMXI vs PLRX Comparison
IMXI vs PLRX Comparison
Compare IMXI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- PLRX
- Stock Information
- Founded
- IMXI 1994
- PLRX 2015
- Country
- IMXI United States
- PLRX United States
- Employees
- IMXI N/A
- PLRX N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- IMXI Technology
- PLRX Health Care
- Exchange
- IMXI Nasdaq
- PLRX Nasdaq
- Market Cap
- IMXI 619.2M
- PLRX 682.2M
- IPO Year
- IMXI N/A
- PLRX 2020
- Fundamental
- Price
- IMXI $19.59
- PLRX $10.92
- Analyst Decision
- IMXI Buy
- PLRX Strong Buy
- Analyst Count
- IMXI 6
- PLRX 7
- Target Price
- IMXI $27.50
- PLRX $40.50
- AVG Volume (30 Days)
- IMXI 124.5K
- PLRX 454.1K
- Earning Date
- IMXI 02-25-2025
- PLRX 02-26-2025
- Dividend Yield
- IMXI N/A
- PLRX N/A
- EPS Growth
- IMXI 21.49
- PLRX N/A
- EPS
- IMXI 1.80
- PLRX N/A
- Revenue
- IMXI $665,673,000.00
- PLRX N/A
- Revenue This Year
- IMXI $2.65
- PLRX N/A
- Revenue Next Year
- IMXI $2.82
- PLRX N/A
- P/E Ratio
- IMXI $10.91
- PLRX N/A
- Revenue Growth
- IMXI 3.79
- PLRX N/A
- 52 Week Low
- IMXI $16.17
- PLRX $10.22
- 52 Week High
- IMXI $23.28
- PLRX $18.92
- Technical
- Relative Strength Index (RSI)
- IMXI 37.28
- PLRX 36.45
- Support Level
- IMXI $19.73
- PLRX $10.68
- Resistance Level
- IMXI $21.41
- PLRX $11.40
- Average True Range (ATR)
- IMXI 0.47
- PLRX 0.71
- MACD
- IMXI -0.11
- PLRX -0.14
- Stochastic Oscillator
- IMXI 13.26
- PLRX 7.92
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.